Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Matthew Caufield is an analyst at HC Wainwright & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/20/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
06/18/2025 | ARDX | Buy Now | Ardelyx | $3.57 | 180.11% | Matthew Caufield38% | → $10 | Assumes | → Buy | Get Alert |
06/17/2025 | MLYS | Buy Now | Mineralys Therapeutics | $13.48 | 211.57% | Matthew Caufield38% | $42 → $42 | Reiterates | Buy → Buy | Get Alert |
06/10/2025 | LYRA | Buy Now | Lyra Therapeutics | $10.83 | 47.74% | Matthew Caufield38% | $2 → $16 | Maintains | Neutral | Get Alert |
06/09/2025 | PHAT | Buy Now | Phathom Pharmaceuticals | $10.51 | 90.29% | Matthew Caufield38% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
06/04/2025 | AKBA | Buy Now | Akebia Therapeutics | $3.64 | 119.78% | Matthew Caufield38% | → $8 | Assumes | → Buy | Get Alert |
05/29/2025 | DMAC | Buy Now | DiaMedica Therapeutics | $3.61 | 177.01% | Matthew Caufield38% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
05/27/2025 | UBX | Buy Now | Unity Biotechnology | $0.79 | 151.76% | Matthew Caufield38% | $4 → $2 | Downgrade | Buy → Neutral | Get Alert |
05/27/2025 | TARS | Buy Now | Tarsus Pharmaceuticals | $41.04 | 75.44% | Matthew Caufield38% | → $72 | Assumes | → Buy | Get Alert |
05/19/2025 | OPTN | Buy Now | OptiNose | — | — | Matthew Caufield38% | $9 → $9 | Reiterates | Neutral → Neutral | Get Alert |
05/19/2025 | ALDX | Buy Now | Aldeyra Therapeutics | $3.04 | 228.95% | Matthew Caufield38% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
05/16/2025 | ZBIO | Buy Now | Zenas BioPharma | $9.19 | 226.44% | Matthew Caufield38% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
05/15/2025 | ADVM | Buy Now | Adverum Biotechnologies | $2.25 | 1233.33% | Matthew Caufield38% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
05/13/2025 | MLYS | Buy Now | Mineralys Therapeutics | $13.48 | 211.57% | Matthew Caufield38% | $42 → $42 | Reiterates | Buy → Buy | Get Alert |
05/12/2025 | SRZN | Buy Now | Surrozen | $9.99 | 220.32% | Matthew Caufield38% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
05/08/2025 | LENZ | Buy Now | LENZ Therapeutics | $29.94 | 26.92% | Matthew Caufield38% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
05/02/2025 | PHAT | Buy Now | Phathom Pharmaceuticals | $10.51 | 90.29% | Matthew Caufield38% | $28 → $20 | Maintains | Buy | Get Alert |
05/01/2025 | IMUX | Buy Now | Immunic | $0.73 | 1269.86% | Matthew Caufield38% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
04/23/2025 | UBX | Buy Now | Unity Biotechnology | $0.79 | 403.52% | Matthew Caufield38% | $4 → $4 | Reiterates | Buy → Buy | Get Alert |
04/16/2025 | LENZ | Buy Now | LENZ Therapeutics | $29.94 | 26.92% | Matthew Caufield38% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
04/16/2025 | ADVM | Buy Now | Adverum Biotechnologies | $2.25 | 1233.33% | Matthew Caufield38% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
04/15/2025 | IMUX | Buy Now | Immunic | $0.73 | 1269.86% | Matthew Caufield38% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
04/04/2025 | ALDX | Buy Now | Aldeyra Therapeutics | $3.04 | 228.95% | Matthew Caufield38% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
04/02/2025 | MLYS | Buy Now | Mineralys Therapeutics | $13.48 | 211.57% | Matthew Caufield38% | $30 → $42 | Maintains | Buy | Get Alert |
04/02/2025 | SRZN | Buy Now | Surrozen | $9.99 | 220.32% | Matthew Caufield38% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
04/01/2025 | FBLG | Buy Now | FibroBiologics | $0.72 | 1571.31% | Matthew Caufield38% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
04/01/2025 | IRD | Buy Now | Opus Genetics | $0.95 | 741.22% | Matthew Caufield38% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
03/31/2025 | HLVX | Buy Now | HilleVax | $1.83 | 9.29% | Matthew Caufield38% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
03/31/2025 | KOD | Buy Now | Kodiak Sciences | $3.62 | -17.13% | Matthew Caufield38% | $3 → $3 | Reiterates | Neutral → Neutral | Get Alert |
03/25/2025 | OPT | Buy Now | Opthea | $3.31 | -39.58% | Matthew Caufield38% | $12 → $2 | Downgrade | Buy → Neutral | Get Alert |
03/25/2025 | UBX | Buy Now | Unity Biotechnology | $0.79 | 403.52% | Matthew Caufield38% | $8 → $4 | Maintains | Buy | Get Alert |
03/24/2025 | UBX | Buy Now | Unity Biotechnology | $0.79 | 403.52% | Matthew Caufield38% | $8 → $4 | Maintains | Buy | Get Alert |
03/21/2025 | EYEN | Buy Now | Eyenovia | $4.21 | -52.49% | Matthew Caufield38% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
03/21/2025 | OPTN | Buy Now | OptiNose | — | — | Matthew Caufield38% | $18 → $9 | Downgrade | Buy → Neutral | Get Alert |
03/19/2025 | DMAC | Buy Now | DiaMedica Therapeutics | $3.61 | 177.01% | Matthew Caufield38% | $7 → $10 | Maintains | Buy | Get Alert |
03/14/2025 | LYRA | Buy Now | Lyra Therapeutics | $10.83 | -81.53% | Matthew Caufield38% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
03/12/2025 | ZBIO | Buy Now | Zenas BioPharma | $9.19 | 226.44% | Matthew Caufield38% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
03/10/2025 | MLYS | Buy Now | Mineralys Therapeutics | $13.48 | 122.55% | Matthew Caufield38% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
03/10/2025 | UBX | Buy Now | Unity Biotechnology | $0.79 | 907.05% | Matthew Caufield38% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
03/07/2025 | PHAT | Buy Now | Phathom Pharmaceuticals | $10.51 | 166.41% | Matthew Caufield38% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
03/03/2025 | ALDX | Buy Now | Aldeyra Therapeutics | $3.04 | 228.95% | Matthew Caufield38% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
03/03/2025 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.13 | 771.67% | Matthew Caufield38% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
02/28/2025 | OPT | Buy Now | Opthea | $3.31 | 262.54% | Matthew Caufield38% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
02/21/2025 | IMUX | Buy Now | Immunic | $0.73 | 1269.86% | Matthew Caufield38% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
02/19/2025 | IRD | Buy Now | Opus Genetics | $0.95 | 741.22% | Matthew Caufield38% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
02/13/2025 | MLYS | Buy Now | Mineralys Therapeutics | $13.48 | 122.55% | Matthew Caufield38% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
02/13/2025 | FBLG | Buy Now | FibroBiologics | $0.72 | 1571.31% | Matthew Caufield38% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
02/10/2025 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.13 | 771.67% | Matthew Caufield38% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
02/06/2025 | EYEN | Buy Now | Eyenovia | $4.21 | -52.49% | Matthew Caufield38% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
01/30/2025 | SRZN | Buy Now | Surrozen | $9.99 | 220.32% | Matthew Caufield38% | → $32 | Initiates | → Buy | Get Alert |
01/29/2025 | OPT | Buy Now | Opthea | $3.31 | 262.54% | Matthew Caufield38% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
01/13/2025 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.13 | 771.67% | Matthew Caufield38% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
01/03/2025 | OPTN | Buy Now | OptiNose | — | — | Matthew Caufield38% | $5 → $18 | Maintains | Buy | Get Alert |
12/16/2024 | ZBIO | Buy Now | Zenas BioPharma | $9.19 | 226.44% | Matthew Caufield38% | → $30 | Initiates | → Buy | Get Alert |
12/12/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $10.51 | 166.41% | Matthew Caufield38% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
12/12/2024 | IRD | Buy Now | Opus Genetics | $0.95 | 741.22% | Matthew Caufield38% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
11/25/2024 | IMUX | Buy Now | Immunic | $0.73 | 1269.86% | Matthew Caufield38% | → $10 | Initiates | → Buy | Get Alert |
11/19/2024 | ADVM | Buy Now | Adverum Biotechnologies | $2.25 | 1233.33% | Matthew Caufield38% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
11/18/2024 | EYEN | Buy Now | Eyenovia | $4.21 | -52.49% | Matthew Caufield38% | $12 → $2 | Downgrade | Buy → Neutral | Get Alert |
11/15/2024 | KOD | Buy Now | Kodiak Sciences | $3.62 | -17.13% | Matthew Caufield38% | $3 → $3 | Reiterates | Neutral → Neutral | Get Alert |
11/15/2024 | DMAC | Buy Now | DiaMedica Therapeutics | $3.61 | 93.91% | Matthew Caufield38% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
11/14/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.13 | 771.67% | Matthew Caufield38% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
11/13/2024 | FBLG | Buy Now | FibroBiologics | $0.72 | 1571.31% | Matthew Caufield38% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
11/13/2024 | EYEN | Buy Now | Eyenovia | $4.21 | 185.04% | Matthew Caufield38% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
11/13/2024 | OPTN | Buy Now | OptiNose | — | — | Matthew Caufield38% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
11/12/2024 | MLYS | Buy Now | Mineralys Therapeutics | $13.48 | 122.55% | Matthew Caufield38% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
11/07/2024 | LENZ | Buy Now | LENZ Therapeutics | $29.94 | 26.92% | Matthew Caufield38% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
10/31/2024 | MLYS | Buy Now | Mineralys Therapeutics | $13.48 | 122.55% | Matthew Caufield38% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
10/30/2024 | FBLG | Buy Now | FibroBiologics | $0.72 | 1571.31% | Matthew Caufield38% | → $12 | Initiates | → Buy | Get Alert |
10/10/2024 | DMAC | Buy Now | DiaMedica Therapeutics | $3.61 | 93.91% | Matthew Caufield38% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
10/07/2024 | DMAC | Buy Now | DiaMedica Therapeutics | $3.61 | 93.91% | Matthew Caufield38% | → $7 | Initiates | → Buy | Get Alert |
09/24/2024 | KOD | Buy Now | Kodiak Sciences | $3.62 | -17.13% | Matthew Caufield38% | $3 → $3 | Reiterates | Neutral → Neutral | Get Alert |
09/19/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.13 | 771.67% | Matthew Caufield38% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
09/05/2024 | KOD | Buy Now | Kodiak Sciences | $3.62 | -17.13% | Matthew Caufield38% | → $3 | Initiates | → Neutral | Get Alert |
09/03/2024 | OPT | Buy Now | Opthea | $3.31 | 262.54% | Matthew Caufield38% | $14 → $12 | Maintains | Buy | Get Alert |
08/15/2024 | LYRA | Buy Now | Lyra Therapeutics | $10.83 | -81.53% | Matthew Caufield38% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
08/15/2024 | LENZ | Buy Now | LENZ Therapeutics | $29.94 | 26.92% | Matthew Caufield38% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
08/15/2024 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield38% | $20 → $18 | Maintains | Buy | Get Alert |
08/15/2024 | MLYS | Buy Now | Mineralys Therapeutics | $13.48 | 122.55% | Matthew Caufield38% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
08/13/2024 | ADVM | Buy Now | Adverum Biotechnologies | $2.25 | 1233.33% | Matthew Caufield38% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
08/13/2024 | EYEN | Buy Now | Eyenovia | $4.21 | 185.04% | Matthew Caufield38% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
08/12/2024 | HLVX | Buy Now | HilleVax | $1.83 | 9.29% | Matthew Caufield38% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
08/12/2024 | LENZ | Buy Now | LENZ Therapeutics | $29.94 | 26.92% | Matthew Caufield38% | → $38 | Initiates | → Buy | Get Alert |
08/12/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $10.51 | 166.41% | Matthew Caufield38% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
08/09/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.13 | 771.67% | Matthew Caufield38% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
08/09/2024 | ALDX | Buy Now | Aldeyra Therapeutics | $3.04 | 228.95% | Matthew Caufield38% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
08/02/2024 | ALDX | Buy Now | Aldeyra Therapeutics | $3.04 | 228.95% | Matthew Caufield38% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
07/24/2024 | EYEN | Buy Now | Eyenovia | $4.21 | 185.04% | Matthew Caufield38% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
07/19/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $10.51 | 166.41% | Matthew Caufield38% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
07/10/2024 | MLYS | Buy Now | Mineralys Therapeutics | $13.48 | 122.55% | Matthew Caufield38% | → $30 | Initiates | → Buy | Get Alert |
07/09/2024 | HLVX | Buy Now | HilleVax | $1.83 | — | Matthew Caufield38% | — | Downgrade | Buy → Neutral | Get Alert |
06/07/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.13 | 771.67% | Matthew Caufield38% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
05/16/2024 | EYEN | Buy Now | Eyenovia | $4.21 | 185.04% | Matthew Caufield38% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
05/15/2024 | OPTN | Buy Now | OptiNose | — | — | Matthew Caufield38% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
05/13/2024 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield38% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
05/13/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.13 | 771.67% | Matthew Caufield38% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
05/10/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $10.51 | 166.41% | Matthew Caufield38% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
05/10/2024 | HLVX | Buy Now | HilleVax | $1.83 | 1430.05% | Matthew Caufield38% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
05/10/2024 | ADVM | Buy Now | Adverum Biotechnologies | $2.25 | 1233.33% | Matthew Caufield38% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
05/07/2024 | LYRA | Buy Now | Lyra Therapeutics | $10.83 | -81.53% | Matthew Caufield38% | → $2 | Downgrade | Buy → Neutral | Get Alert |
05/06/2024 | ALDX | Buy Now | Aldeyra Therapeutics | $3.04 | 228.95% | Matthew Caufield38% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
05/01/2024 | LYRA | Buy Now | Lyra Therapeutics | $10.83 | 10.8% | Matthew Caufield38% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
04/30/2024 | ADVM | Buy Now | Adverum Biotechnologies | $2.25 | 1233.33% | Matthew Caufield38% | → $30 | Initiates | → Buy | Get Alert |
04/29/2024 | OPTN | Buy Now | OptiNose | — | — | Matthew Caufield38% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
04/02/2024 | ALDX | Buy Now | Aldeyra Therapeutics | $3.04 | 228.95% | Matthew Caufield38% | → $10 | Reinstates | Buy → Buy | Get Alert |
03/22/2024 | LYRA | Buy Now | Lyra Therapeutics | $10.83 | 10.8% | Matthew Caufield38% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
03/21/2024 | HLVX | Buy Now | HilleVax | $1.83 | 1430.05% | Matthew Caufield38% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
03/19/2024 | EYEN | Buy Now | Eyenovia | $4.21 | 185.04% | Matthew Caufield38% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
03/18/2024 | OPTN | Buy Now | OptiNose | — | — | Matthew Caufield38% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
03/11/2024 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield38% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
03/11/2024 | OPTN | Buy Now | OptiNose | — | — | Matthew Caufield38% | → $5 | Initiates | → Buy | Get Alert |
03/08/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $10.51 | 166.41% | Matthew Caufield38% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
03/06/2024 | EYEN | Buy Now | Eyenovia | $4.21 | 185.04% | Matthew Caufield38% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
03/01/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.13 | 771.67% | Matthew Caufield38% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
12/13/2023 | HLVX | Buy Now | HilleVax | $1.83 | 1430.05% | Matthew Caufield38% | → $28 | Initiates | → Buy | Get Alert |
11/14/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield38% | → $20 | Reiterates | Buy → Buy | Get Alert |
11/14/2023 | UBX | Buy Now | Unity Biotechnology | $0.79 | 1158.81% | Matthew Caufield38% | → $10 | Reiterates | Buy → Buy | Get Alert |
11/14/2023 | EYEN | Buy Now | Eyenovia | $4.21 | 185.04% | Matthew Caufield38% | → $12 | Reiterates | Buy → Buy | Get Alert |
10/02/2023 | LYRA | Buy Now | Lyra Therapeutics | $10.83 | 10.8% | Matthew Caufield38% | → $12 | Reiterates | Buy → Buy | Get Alert |
08/31/2023 | LYRA | Buy Now | Lyra Therapeutics | $10.83 | 10.8% | Matthew Caufield38% | → $12 | Initiates | → Buy | Get Alert |
08/22/2023 | FN | Buy Now | Fabrinet | $266.19 | -89.48% | Matthew Caufield38% | → $28 | Reiterates | Buy → Buy | Get Alert |
08/18/2023 | EYEN | Buy Now | Eyenovia | $4.21 | 185.04% | Matthew Caufield38% | → $12 | Reiterates | Buy → Buy | Get Alert |
08/14/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield38% | → $20 | Reiterates | Buy → Buy | Get Alert |
08/11/2023 | PHAT | Buy Now | Phathom Pharmaceuticals | $10.51 | 166.41% | Matthew Caufield38% | → $28 | Reiterates | Buy → Buy | Get Alert |
08/11/2023 | EYEN | Buy Now | Eyenovia | $4.21 | 185.04% | Matthew Caufield38% | → $12 | Reiterates | Buy → Buy | Get Alert |
08/10/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.13 | 771.67% | Matthew Caufield38% | → $36 | Reiterates | Buy → Buy | Get Alert |
08/09/2023 | PHAT | Buy Now | Phathom Pharmaceuticals | $10.51 | 166.41% | Matthew Caufield38% | → $28 | Initiates | → Buy | Get Alert |
08/09/2023 | UBX | Buy Now | Unity Biotechnology | $0.79 | 1158.81% | Matthew Caufield38% | → $10 | Reiterates | Buy → Buy | Get Alert |
08/01/2023 | OPT | Buy Now | Opthea | $3.31 | 322.96% | Matthew Caufield38% | → $14 | Reiterates | Buy → Buy | Get Alert |
07/31/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.13 | 771.67% | Matthew Caufield38% | → $36 | Reiterates | Buy → Buy | Get Alert |
06/30/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $3.04 | 393.42% | Matthew Caufield38% | → $15 | Reiterates | Buy → Buy | Get Alert |
06/22/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $3.04 | 393.42% | Matthew Caufield38% | → $15 | Reiterates | Buy → Buy | Get Alert |
06/16/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $3.04 | 393.42% | Matthew Caufield38% | → $15 | Reiterates | Buy → Buy | Get Alert |
06/08/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.13 | 771.67% | Matthew Caufield38% | → $36 | Reiterates | Buy → Buy | Get Alert |
05/16/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield38% | → $20 | Reiterates | Buy → Buy | Get Alert |
05/12/2023 | EYEN | Buy Now | Eyenovia | $4.21 | 185.04% | Matthew Caufield38% | → $12 | Reiterates | Buy → Buy | Get Alert |
05/11/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.13 | 771.67% | Matthew Caufield38% | → $36 | Reiterates | Buy → Buy | Get Alert |
05/10/2023 | UBX | Buy Now | Unity Biotechnology | $0.79 | 1158.81% | Matthew Caufield38% | → $10 | Reiterates | → Buy | Get Alert |
05/05/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $3.04 | 393.42% | Matthew Caufield38% | → $15 | Reiterates | → Buy | Get Alert |
05/02/2023 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield38% | $35 → $40 | Downgrade | Buy → Neutral | Get Alert |
04/28/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.13 | 771.67% | Matthew Caufield38% | → $36 | Reiterates | → Buy | Get Alert |
04/19/2023 | EYEN | Buy Now | Eyenovia | $4.21 | 185.04% | Matthew Caufield38% | → $12 | Reiterates | → Buy | Get Alert |
04/03/2023 | EYEN | Buy Now | Eyenovia | $4.21 | 185.04% | Matthew Caufield38% | → $12 | Reiterates | → Buy | Get Alert |
03/31/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield38% | → $20 | Reiterates | → Buy | Get Alert |
03/28/2023 | UBX | Buy Now | Unity Biotechnology | $0.79 | 1158.81% | Matthew Caufield38% | → $10 | Reiterates | → Buy | Get Alert |
03/16/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.13 | 771.67% | Matthew Caufield38% | → $36 | Reiterates | → Buy | Get Alert |
03/10/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $3.04 | 393.42% | Matthew Caufield38% | → $15 | Reiterates | → Buy | Get Alert |
03/02/2023 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield38% | → $35 | Reiterates | → Buy | Get Alert |
03/01/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $3.04 | 393.42% | Matthew Caufield38% | → $15 | Reiterates | → Buy | Get Alert |
02/24/2023 | OPT | Buy Now | Opthea | $3.31 | 322.96% | Matthew Caufield38% | → $14 | Reiterates | → Buy | Get Alert |
02/23/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.13 | 771.67% | Matthew Caufield38% | → $36 | Reiterates | → Buy | Get Alert |
02/17/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield38% | → $20 | Reiterates | → Buy | Get Alert |
02/17/2023 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield38% | → $35 | Reiterates | → Buy | Get Alert |
02/06/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.13 | 771.67% | Matthew Caufield38% | → $36 | Reiterates | → Buy | Get Alert |
01/26/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield38% | $26 → $20 | Maintains | Buy | Get Alert |
12/08/2022 | OPT | Buy Now | Opthea | $3.31 | 322.96% | Matthew Caufield38% | → $14 | Initiates | → Buy | Get Alert |
11/18/2022 | FDMT | Buy Now | 4D Molecular Therapeutics | $4.13 | 771.67% | Matthew Caufield38% | → $36 | Initiates | → Buy | Get Alert |
11/04/2022 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield38% | $26 → $35 | Maintains | Buy | Get Alert |
10/05/2022 | EYEN | Buy Now | Eyenovia | $4.21 | 185.04% | Matthew Caufield38% | → $12 | Initiates | → Buy | Get Alert |
07/18/2022 | OYST | Buy Now | Oyster Point Pharma | — | — | Matthew Caufield38% | → $20 | Initiates | → Buy | Get Alert |
11/10/2021 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield38% | $20 → $26 | Maintains | Buy | Get Alert |
08/19/2021 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield38% | → $20 | Initiates | → Buy | Get Alert |